2025
SJR Q3
JCR Q3 · 2,2
161 matched articles
SCIE
Journal detail
Cancer Investigation
- Publisher
- Taylor & Francis Group LLC Philadelphia
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0735790715324192
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,495
- Quartile Q3
- H-Index 97
- Cites/doc 1,9
- Docs (3y) 243
- Cites (3y) 406
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,2
- 5Y JIF 1,9
- JCI 0,41
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,495 | 2,2 | 1,9 | 0,41 | Q3 | 97 |
| 2024 | Q3 | Q3 | 0,505 | 1,9 | 1,7 | 0,37 | Q4 | 96 |
| 2023 | Q2 | Q3 | 0,604 | 1,8 | 2,1 | 0,39 | Q4 | 96 |
| 2022 | Q2 | Q4 | 0,598 | 2,4 | 2,3 | 0,41 | Q3 | 96 |
| 2021 | Q2 | Q4 | 0,568 | 2,4 | 2,5 | 0,41 | Q4 | 96 |
| 2020 | Q2 | Q4 | 0,688 | 2,2 | 2,3 | 0,47 | Q3 | 96 |
| 2019 | Q1 | Q3 | 0,984 | 2,4 | 2,2 | 0,52 | Q3 | 96 |
| 2018 | — | Q4 | — | 2 | 2 | 0,49 | Q3 | — |
| 2017 | Q2 | Q4 | 0,858 | 2,1 | 2,2 | 0,52 | Q3 | 96 |
| 2016 | Q2 | Q3 | 0,878 | 2 | 2 | — | — | 96 |
| 2015 | Q1 | Q3 | 1,057 | 2,2 | 2 | — | — | 96 |
| 2014 | Q1 | Q3 | 1,013 | 2,2 | 2 | — | — | 96 |
| 2013 | Q1 | Q3 | 1,087 | 2,1 | 2,1 | — | — | 96 |
| 2012 | Q1 | Q3 | 1,114 | 2,2 | 2,3 | — | — | 96 |
| 2011 | Q1 | Q3 | 1,041 | 1,8 | 1,9 | — | — | 96 |
| 2010 | Q1 | Q3 | 1,031 | 2,4 | 2,2 | — | — | 96 |
| 2009 | — | Q3 | — | 2,1 | 2,1 | — | — | — |
| 2008 | — | Q3 | — | 2 | 2,3 | — | — | — |
| 2007 | — | Q3 | — | 2,1 | 2 | — | — | — |
| 2006 | — | Q3 | — | 2,3 | — | — | — | — |
| 2005 | — | Q3 | — | 1,8 | — | — | — | — |
| 2004 | — | Q3 | — | 1,9 | — | — | — | — |
| 2003 | — | Q3 | — | 2,1 | — | — | — | — |
| 2002 | — | Q3 | — | 1,9 | — | — | — | — |
| 2001 | — | Q3 | — | 1,6 | — | — | — | — |
| 2000 | — | Q3 | — | 1,5 | — | — | — | — |
| 1999 | — | Q3 | — | 1,5 | — | — | — | — |
| 1998 | — | Q2 | — | 1,7 | — | — | — | — |
| 1997 | — | Q2 | — | 1,6 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q3 | Q3 | 228/333 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q4 | 243/328 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q4 | 241/322 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q3 | 189/241 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q4 | 211/245 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q3 | 220/242 |
| 2019 | ONCOLOGY | SCIE | Q3 | Q3 | 174/244 |
| 2018 | ONCOLOGY | SCIE | Q4 | Q3 | 184/230 |
| 2017 | ONCOLOGY | SCIE | Q4 | Q3 | 171/223 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 159/217 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 141/213 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 142/211 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 135/203 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 114/197 |
| 2011 | ONCOLOGY | SCIE | Q3 | — | 130/196 |
| 2010 | ONCOLOGY | SCIE | Q3 | — | 99/185 |
| 2009 | ONCOLOGY | SCIE | Q3 | — | 97/166 |
| 2008 | ONCOLOGY | SCIE | Q3 | — | 102/143 |
| 2007 | ONCOLOGY | SCIE | Q3 | — | 86/132 |
| 2006 | ONCOLOGY | SCIE | Q3 | — | 68/127 |
| 2005 | ONCOLOGY | SCIE | Q3 | — | 76/123 |
| 2004 | ONCOLOGY | SCIE | Q3 | — | 72/123 |
| 2003 | ONCOLOGY | SCIE | Q3 | — | 63/120 |
| 2002 | ONCOLOGY | SCIE | Q3 | — | 62/114 |
| 2001 | ONCOLOGY | SCIE | Q3 | — | 58/107 |
| 2000 | ONCOLOGY | SCIE | Q3 | — | 57/103 |
| 1999 | ONCOLOGY | SCIE | Q3 | — | 54/105 |
| 1998 | ONCOLOGY | SCIE | Q2 | — | 45/104 |
| 1997 | ONCOLOGY | SCIE | Q2 | — | 39/102 |